Profound Medical Corp. (PROF) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
PROF currently has 36.3M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 61.52% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 12, 2026 |
S-3 filing: This S-3 filing is a shelf registration statement allowing selling shareholders to offer and sell shares of common stock from time to time. |
36M | 0 |
| May 07, 2026 |
10-Q filing | 36.3M shares outstanding |
36M | 0 |
| Dec 19, 2025 |
8-K filing: Profound Medical Corp. entered into a Securities Purchase Agreement with investors to issue and sell 5,142,870 common shares at $7.00 per share in a registered direct offering, for gross proceeds of $36 million, and intends to complete a private placement of up to 571,428 common shares at $7.00 per share for gross proceeds of up to $4 million. ($40.0M proceeds) |
30M | 0 |
| Nov 13, 2025 |
S-3 filing: Profound Medical Corp. may offer and sell common shares, warrants, debt securities, subscription receipts, and units from time to time in one or more offerings of up to $150,000,000 in aggregate offering price. |
30M | 0 |
| Nov 13, 2025 |
10-Q filing | 30.1M shares outstanding |
30M | 0 |
| Aug 14, 2025 |
10-Q filing | 30.1M shares outstanding |
30M | 0 |
| May 08, 2025 |
10-Q filing | 30.0M shares outstanding |
30M | 0 |
| Mar 07, 2025 |
10-K filing | 30.0M shares outstanding |
30M | 0 |
| Jun 14, 2024 |
F-10 filing: Profound Medical Corp. may offer and issue common shares, warrants, debt securities, subscription receipts or units for up to an aggregate initial offering price of US$150,000,000. |
21M | 0 |
| Mar 07, 2024 |
40-F filing | 21.4M shares outstanding |
21M | 0 |
| Mar 07, 2023 |
40-F filing | 20.9M shares outstanding |
21M | 0 |
| Mar 03, 2022 |
40-F filing | 20.8M shares outstanding |
21M | 0 |
| Mar 03, 2022 |
F-10 filing: Profound Medical Corp. may offer and issue common shares, warrants, debt securities, subscription receipts, or units for up to an aggregate initial offering price of US$100,000,000. |
20M | 0 |
| Mar 02, 2021 |
40-F filing | 20.2M shares outstanding |
20M | 0 |
| Mar 03, 2020 |
40-F filing | 11.9M shares outstanding |
12M | 0 |